| A Study of Modified mRNA Vaccines in Healthy Adults (NCT05397223) | ModernaTX, Inc. | 2022-05-24 |
| A Study to Evaluate the Anti-inflammatory Effects of Letermovir (Prevymis) in Adults With Human Immunodeficiency Virus (HIV)-1 and Asymptomatic Cytomegalovirus (CMV) Who Are on Suppressive Antiretroviral Therapy, Plus Its Effect on Chronic Inflammation, HIV Persistence and Other Clinical Outcomes. (NCT04840199) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-04-19 |
| Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT (NCT03665675) | Sumithira Vasu | 2020-11-07 |
| Clinical Performance Evaluation of DxN CMV Assay (NCT03127787) | Beckman Coulter, Inc. | 2016-06-01 |
| Review of Human Herpes Viruses in Burns (NCT02452229) | The University of Texas Medical Branch, Galveston | 2015-03-01 |
| Clinical Validation of Lophius Biosciences Kit T-Track® CMV in Kidney Transplant Recipients (NCT02083042) | Lophius Biosciences GmbH | 2013-08-01 |
| Primary Transplant Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation (NCT01646645) | Memorial Sloan Kettering Cancer Center | 2012-07-13 |
| The Prevelance Rate of Human Cytomegalovirus (HCMV), Epstein-Barr Virus (EBV) and Human Herpes Virus (HHV-6) in a Saliva of the Patient With Periodantitis (NCT01248598) | Rambam Health Care Campus | 2010-10-01 |
| Safety Study of Four Chimera Cytomegalovirus (CMV) Vaccines in Healthy Adult Males 30-50 Years of Age (NCT01195571) | CMV Research Foundation | 2010-09-01 |
| The Benefits Feasibility and Acceptability of Extended Screening Testing in Newborn Babies Who Are Referred for Further Hearing Assessment (NCT01162330) | Newcastle-upon-Tyne Hospitals NHS Trust | 2010-08-01 |
| Seroprevalence Study of Hepatitis A, Varicella-Zoster, Cytomegalovirus, Herpes Simplex and Bordetella Pertussis (NCT01160081) | GlaxoSmithKline | 2010-03-01 |
| Detection of Human Cytomegalovirus in the Saliva (NCT00815802) | University Hospital, Limoges | 2007-07-01 |
| Effect of Burn Size on Cytomegalovirus Reactivation and Correlates of T Cell Immune Function in Burned Patients (NCT00467532) | University of North Carolina, Chapel Hill | 2007-03-01 |
| CMV Disease and IRIS in HIV-1 Infected Persons (NCT00456664) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2006-11-01 |
| Valganciclovir in Prevention of Cytomegalovirus (CMV) Reactivation Following Allogeneic-Stem Cell Transplantation (SCT) (NCT00330018) | Hadassah Medical Organization | 2006-02-01 |
| Cytomegalovirus Reactivation in Cancer Patients Receiving Chemotherapy (NCT00366717) | Mackay Memorial Hospital | 2005-06-01 |
| Cytomegalovirus (CMV) Transmission by Frozen Breast Milk in Preterms (NCT00668798) | Johann Wolfgang Goethe University Hospital | 2005-01-01 |
| The Impact of Cytogam® on Time to Viral Load Reduction in Kidney or Kidney/Pancreas Transplant Recipients With Clinical CMV Disease (NCT00214240) | University of Wisconsin, Madison | 2000-01-01 |